These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2534920)

  • 21. Suppressor T cell activity in rheumatoid arthritis and systemic lupus erythematosus.
    Sakane T; Taniguchi Y; Honda M; Kotani H
    Ryumachi; 1981; 21 Suppl():115-22. PubMed ID: 6211784
    [No Abstract]   [Full Text] [Related]  

  • 22. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
    Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
    Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus.
    Barath S; Aleksza M; Tarr T; Sipka S; Szegedi G; Kiss E
    Lupus; 2007; 16(7):489-96. PubMed ID: 17670847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Oral lesions in systemic lupus erythematosus. I. The etiopathogenic aspects of lupus erythematosus].
    Bonaccorso A; Tripi TR
    Minerva Stomatol; 1998; 47(1-2):27-31. PubMed ID: 9578644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lupus erythematosus. 3. Investigation of oral lesions: a) Epidemiology, b) Clinical picture, c) Histopathology, d) Ultrastructural aspects].
    Frojo M; Palomba F; Rullo R
    Arch Stomatol (Napoli); 1989 Nov; 30(5):975-97. PubMed ID: 2701788
    [No Abstract]   [Full Text] [Related]  

  • 26. Epstein-Barr virus and systemic lupus erythematosus.
    James JA; Harley JB; Scofield RH
    Curr Opin Rheumatol; 2006 Sep; 18(5):462-7. PubMed ID: 16896283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular immunological dysfunction in systemic lupus erythematosus.
    Chee YC
    Singapore Med J; 1982 Feb; 23(1):12-8. PubMed ID: 6214005
    [No Abstract]   [Full Text] [Related]  

  • 28. Phenotypic expression of Vicia villosa binding T cell subsets, as markers of contrasuppressor cells in systemic lupus erythematosus.
    Fortune F; Lehner T
    Clin Exp Immunol; 1988 Oct; 74(1):100-4. PubMed ID: 2975536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A preliminary study on T lymphocyte subsets in systemic lupus erythematosus.
    Yang JL; Chen PZ; Dong Y; Tang FL; Zhang NZ
    Chin Med J (Engl); 1988 Sep; 101(9):665-70. PubMed ID: 2976662
    [No Abstract]   [Full Text] [Related]  

  • 30. [Morphologic and immunomorphologic studies in rheumatoid arthritis and systemic lupus erythematosus].
    Wagner T
    Patol Pol; 1984; 35(1):45-64. PubMed ID: 6333663
    [No Abstract]   [Full Text] [Related]  

  • 31. The pathogenesis of immune dysregulation in systemic lupus erythematosus. A troika.
    Alarcón-Segovia D
    J Rheumatol; 1984 Oct; 11(5):588-90. PubMed ID: 6239922
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of steroids on the frequency of regulatory T cells and expression of FOXP3 in a patient with systemic lupus erythematosus: a two-year follow-up.
    Cepika AM; Marinic I; Morovic-Vergles J; Soldo-Juresa D; Gagro A
    Lupus; 2007; 16(5):374-7. PubMed ID: 17576742
    [No Abstract]   [Full Text] [Related]  

  • 33. [Association of systemic lupus erythematosus and Sjögren's syndrome].
    Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
    Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Specificity of antibodies against native DNA using Crithidia luciliae. Clinical and analytical features of patients with and without antibodies against native DNA in systemic lupus erythematosus].
    Peña Sagredo JL; Riestra Noriega JL; Sánchez Andrada S; Luceño Vázquez A; Rodríguez Valverde V
    Med Clin (Barc); 1984 Jun; 83(3):94-6. PubMed ID: 6384685
    [No Abstract]   [Full Text] [Related]  

  • 35. [Seronegative systemic lupus erythematosus and autoimmune thyroiditis].
    González-Gay MA; Cereijo MJ; Agüero JJ; Alonso MD; Fernández Sueiro JL; Vidal JI
    An Med Interna; 1993 Aug; 10(8):393-4. PubMed ID: 8218785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical presentation of systemic lupus erythematosus in Saudi patients.
    Al Nahdi MS; Al Mohaya S; Al Fadel Saleh M; Al Awamy BH; Abdulrahman IS
    Trop Geogr Med; 1987 Apr; 39(2):187-90. PubMed ID: 3629714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of menopause on the activity of systemic lupus erythematosus].
    Cabral AR
    Rev Invest Clin; 2002; 54(2):166-8. PubMed ID: 12053816
    [No Abstract]   [Full Text] [Related]  

  • 38. Manipulation of immune regulation in systemic lupus erythematosus.
    La Cava A; Fang CJ; Singh RP; Ebling F; Hahn BH
    Autoimmun Rev; 2005 Nov; 4(8):515-9. PubMed ID: 16214088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Systemic lupus erythematosus: disease or syndrome?].
    Font J; Cardellach F
    Med Clin (Barc); 1985 Apr; 84(16):657-9. PubMed ID: 3875769
    [No Abstract]   [Full Text] [Related]  

  • 40. [T-suppressor functional activity in systemic lupus erythematosus and chronic glomerulonephritis].
    Gordovskaia NB; Denisov VN; Krasnova TN
    Ter Arkh; 1982; 54(7):29-32. PubMed ID: 6215736
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.